Home/Filings/4/0001062993-23-017640
4//SEC Filing

Dahowski Diane 4

Accession 0001062993-23-017640

CIK 0000012208other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 12:56 PM ET

Size

28.9 KB

Accession

0001062993-23-017640

Insider Transaction Report

Form 4
Period: 2023-09-01
Dahowski Diane
EVP, Global Supply Chain
Transactions
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2023-09-02+36111,357.028 total
  • Tax Payment

    Bio-Rad A Common Stock

    2023-09-02$394.60/sh125$49,32511,232.028 total
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2023-09-01+52010,961.028 total
  • Tax Payment

    Bio-Rad A Common Stock

    2023-09-01$394.60/sh114$44,98410,996.028 total
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2023-09-04+60012,155.028 total
  • Tax Payment

    Bio-Rad A Common Stock

    2023-09-03$394.60/sh172$67,87111,555.028 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-015201,562 total
    Exercise: $0.00Bio-Rad A Common Stock (520 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-01329659 total
    Exercise: $0.00Bio-Rad A Common Stock (329 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-03495495 total
    Exercise: $0.00Bio-Rad A Common Stock (495 underlying)
  • Tax Payment

    Bio-Rad A Common Stock

    2023-09-01$394.60/sh180$71,02810,781.028 total
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2023-09-01+32911,110.028 total
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2023-09-03+49511,727.028 total
  • Tax Payment

    Bio-Rad A Common Stock

    2023-09-04$394.60/sh275$108,51511,880.028 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-02361361 total
    Exercise: $0.00Bio-Rad A Common Stock (361 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-046000 total
    Exercise: $0.00Bio-Rad A Common Stock (600 underlying)
Footnotes (8)
  • [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
  • [F2]Includes 31.8970 and 24.7960 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
  • [F4]On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F5]On September 1, 2021, the reporting person was granted 1,317 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F6]On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F7]On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
  • [F8]On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother

Related Parties

1
  • filerCIK 0001926636

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 12:56 PM ET
Size
28.9 KB